(Q35563634)

8 August 2017

title

Pharmacokinetics and pharmacodynamics of high-dose human regular U-500 insulin versus human regular U-100 insulin in healthy obese subjects (English)

1 reference

8 August 2017

0 references

1 reference

1 reference

1 reference

Marcus Hompesch

8

0 references

Jennie G. Jacobson

object named as

Jennie G Jacobson

10

0 references

author name string

Amparo de la Peña

1

1 reference

8 August 2017

Matthew Riddle

2

1 reference

8 August 2017

Linda A Morrow

3

1 reference

8 August 2017

Honghua H Jiang

4

1 reference

8 August 2017

Helle Linnebjerg

5

1 reference

8 August 2017

Adam Scott

6

1 reference

8 August 2017

Khin M Win

7

1 reference

8 August 2017

Kenneth F Mace

9

1 reference

8 August 2017

Jeffrey A Jackson

11

1 reference

8 August 2017

language of work or name

English

0 references

publication date

12 October 2011

1 reference

8 August 2017

1 reference

8 August 2017

volume

34

1 reference

8 August 2017

issue

12

1 reference

8 August 2017

page(s)

2496-2501

1 reference

Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported

8 August 2017

copyright license

start time

1 September 2021

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Dose-dependent delay of the hypoglycemic effect of short-acting insulin analogs in obese subjects with type 2 diabetes: a pharmacokinetic and pharmacodynamic study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3220843

Use of concentrated insulin human regular (U-500) for patients with diabetes

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3220843

Clinical efficacy and patient satisfaction with U-500 insulin use.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3220843

Standards of medical care in diabetes--2010.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3220843

U-500 regular insulin: clinical experience and pharmacokinetics in obese, severely insulin-resistant type 2 diabetic patients

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3220843

High-dose insulin therapy: is it time for U-500 insulin?

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3220843

Albumin-bound basal insulin analogues (insulin detemir and NN344): comparable time-action profiles but less variability than insulin glargine in type 2 diabetes

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3220843

The use of U-500 in patients with extreme insulin resistance

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3220843

A novel use of U-500 insulin for continuous subcutaneous insulin infusion in patients with insulin resistance: a case series

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3220843

A prospective trial of U500 insulin delivered by Omnipod in patients with type 2 diabetes mellitus and severe insulin resistance

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3220843

Pharmacokinetics and pharmacodynamics of insulin lispro protamine suspension compared with insulin glargine and insulin detemir in type 2 diabetes

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3220843

Clinical experience with U-500 regular insulin in obese, markedly insulin-resistant type 2 diabetic patients.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3220843

Factors influencing the absorption, serum insulin concentration, and blood glucose responses after injections of regular insulin and various insulin mixtures.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3220843

26 September 2018

Insulin Pharmacokinetics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3220843

Five fold increase of insulin concentration delays the absorption of subcutaneously injected human insulin suspensions in pigs

26 September 2018

1 reference

12 December 2020

Absorption of injected insulin. A clinical-pharmacological study

1 reference

12 December 2020

The absorption of subcutaneously injected short-acting soluble insulin: influence of injection technique and concentration

1 reference

12 December 2020

Pharmacokinetic model for the absorption of subcutaneously injected soluble insulin and monomeric insulin analogues

1 reference

12 December 2020

Identifiers

DOI

10.2337/DC11-0721

1 reference

8 August 2017

1 reference

8 August 2017

1 reference